These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8344364)

  • 1. An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism.
    Rowland-Jones SL; Powis SH; Sutton J; Mockridge I; Gotch FM; Murray N; Hill AB; Rosenberg WM; Trowsdale J; McMichael AJ
    Eur J Immunol; 1993 Aug; 23(8):1999-2004. PubMed ID: 8344364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modulation of antigen presentation by HLA-B27 molecules.
    Pazmany L; Rowland-Jones S; Huet S; Hill A; Sutton J; Murray R; Brooks J; McMichael A
    J Exp Med; 1992 Feb; 175(2):361-9. PubMed ID: 1370680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential processing of influenza nucleoprotein in human and mouse cells.
    Braud VM; McMichael AJ; Cerundolo V
    Eur J Immunol; 1998 Feb; 28(2):625-35. PubMed ID: 9521073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different MHC class I alleles compete for presentation of overlapping viral epitopes.
    Tussey LG; Rowland-Jones S; Zheng TS; Androlewicz MJ; Cresswell P; Frelinger JA; McMichael AJ
    Immunity; 1995 Jul; 3(1):65-77. PubMed ID: 7542549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
    Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes.
    Zhou X; Glas R; Momburg F; Hämmerling GJ; Jondal M; Ljunggren HG
    Eur J Immunol; 1993 Aug; 23(8):1796-801. PubMed ID: 8393798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of an HLA B8-restricted influenza epitope by motif.
    Suhrbier A; Schmidt C; Fernan A
    Immunology; 1993 May; 79(1):171-3. PubMed ID: 7685314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.
    Salcedo M; Momburg F; Hämmerling GJ; Ljunggren HG
    J Immunol; 1994 Feb; 152(4):1702-8. PubMed ID: 8120379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
    Dorrell L; O'Callaghan CA; Britton W; Hambleton S; McMichael A; Smith GL; Rowland-Jones S; Blanchard TJ
    Vaccine; 2000 Sep; 19(2-3):327-36. PubMed ID: 10930688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
    Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
    Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
    Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E
    Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping.
    Carreno BM; Koenig S; Coligan JE; Biddison WE
    Mol Immunol; 1992 Sep; 29(9):1131-40. PubMed ID: 1379681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses.
    Bowness P; Moss PA; Rowland-Jones S; Bell JI; McMichael AJ
    Eur J Immunol; 1993 Jul; 23(7):1417-21. PubMed ID: 8391985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
    Bowness P; Allen RL; McMichael AJ
    Eur J Immunol; 1994 Oct; 24(10):2357-63. PubMed ID: 7523137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
    Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
    J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.